|
|
|
| Liquid Chromatography Markets (LC, HPLC and UHPLC) |
|
| Table of Contents Published: 2009/03 Published by: Kalorama Information |
| The liquid chromatography (LC) market has been relatively mature for quite a while, with a slow evolution of products and applications over the last few decades. High performance liquid chromatography (HPLC) has used essentially the same types of componen ... |
| Mesenchymal Stem Cells, Advances & Applications |
|
| Table of Contents Published: 2009/03 Published by: BioInformant |
| This market research report focuses on recent advances in MSC research applications, explores research priorities by market segment, highlights individual labs and end-users of MSC research products, explores the competitive environment for MSC research p ... |
| Bioinformatics Markets |
|
| Table of Contents Published: 2009/03 Published by: Trimark Publications |
| The life science informatics marketplace--known as bioinformatics--is set to expand as high-tech companies infiltrate this arena and biopharmaceutical companies incorporate key informatic solutions into their business strategies. TriMark Publications beli ... |
| Apoptosis 2009: Opportunities in Cancer and Other Diseases |
|
| Table of Contents Published: 2009/02 Published by: Biophoenix Limited |
| Apoptosis is regarded as the major mode of cell death in cancer and should therefore be considered as a potential target when developing new antineoplastic drugs. An increasing number of companies are doing so, and we anticipate that this approach will pa ... |
| Toxicity Screening 2009 Market Report |
|
| Table of Contents Published: 2009/02 Published by: Select Biosciences, Ltd. |
| This is the latest and most up-to-date Toxicity Screening Market Analysis Report from Select Biosciences. This comprehensive report provides a qualitative and quantitative analysis of the toxicity screening space, market metrics, and thorough bottom-up ba ... |
| Cardiac Biomarkers |
|
| Table of Contents Published: 2009/02 Published by: Global Industry Analysts, Inc. |
| This report analyzes the worldwide markets for Cardiac Biomarkers in Millions of US$. ... |
| Protease Inhibitors: Innovation Drives Drug Pipeline |
|
| Table of Contents Published: 2009/02 Published by: Insight Pharma Reports |
| Proteases constitute one of the largest potential drug target enzyme families, with 647 human gene products incorporating protease sequences and mutated proteases having been identified. In addition, there are many more proteases found in viruses, bacteri ... |
| Stem Cell Therapeutics Markets |
|
| Table of Contents Published: 2009/02 Published by: Kalorama Information |
| Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. Congress has also indicated a desire to move forward wit ... |
| Biotech 2009-Life Sciences: Navigating the Sea Change |
|
| Table of Contents Published: 2009/02 Published by: BURRILL & COMPANY |
| Biotech 2009-Life Sciences: Navigating the Sea Change is the 23rd edition of this yearly publication. It provides a compass to guide you through the current financial market turmoil. The 400-plus page book contains analysis and perspectives on the perform ... |
| Chinese Markets for Biopharmaceuticals |
|
| Table of Contents Published: 2009/02 Published by: Asia Market Information & Development Co. |
| China' s demand for Biopharmaceuticals has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, s ... |
| Chinese Markets for Autoimmune Drugs |
|
| Table of Contents Published: 2009/02 Published by: Asia Market Information & Development Co. |
| China' s demand for Autoimmune Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, sup ... |
| Therapeutic Peptides in Oncology: Drug Pipeline Update 2009 |
|
| Table of Contents Published: 2009/01 Published by: BioSeeker Group AB |
| Today, there are 124 companies plus partners developing more than 137 peptide based oncology drugs in more than 226 developmental projects. In addition, the accumulated number of ceased drugs over the last three years amount to another 56 drugs. In all, t ... |
| Analytical Tool - Apoptosis in Oncology |
|
| Published: 2009/01 Published by: BioSeeker Group AB |
| Analytical Tool - Apoptosis in Oncology offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in apoptopic drug development for the treatment of cancer. It is at the same time a map of the research and development ... |
| Analytical Tool - Protein Kinase Inhibitors in Oncology |
|
| Table of Contents Published: 2009/01 Published by: BioSeeker Group AB |
| Analytical Tool - Protein Kinase Inhibitors in Oncology offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in the drug development of protein kinase inhibitors (PKIs) for the treatment of cancer. It is at the s ... |
| Immunotherapy in Oncology: Drug Pipeline Update 2009 |
|
| Table of Contents Published: 2009/01 Published by: BioSeeker Group AB |
| Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the fields of antibodies, vaccines, and immunostimulators ... |
| Apoptosis in Oncology: Drug Pipeline Update 2009 |
|
| Table of Contents Published: 2009/01 Published by: BioSeeker Group AB |
| Cancer cells frequently and possibly invariably possess apoptotic defects. In this context, apoptotic pathways provide exciting molecular targets for new therapeutic agents to specifically promote apoptosis of cancer cells. ... |
| Antibodies in Oncology: Drug Pipeline Update 2009 |
|
| Table of Contents Published: 2009/01 Published by: BioSeeker Group AB |
| The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the second wave in the lucrative field of therapeutic anti ... |
| Customized Health - US - January 2009 |
|
| Table of Contents Published: 2009/01 Published by: Mintel International Group Ltd, |
| Customized health - designing healthcare services based on the unique needs of consumers - is one of the most important trends in the healthcare category, and holds significant opportunities for companies that offer the right products and services. ... |
| Alzheimer's Disease Biomarkers, 2009 |
|
| Table of Contents Published: 2009/01 Published by: BioPharm Reports (Technology and Markets Ltd) |
| This report gives a comprehensive and up-to-date review of Alzheimer' s disease biomarkers. Recent years have seen significant advances in this field. Whilst considerable effort has focused on AƒÀ and tau related markers, a substantial number of other mol ... |
| Royalty Financing Agreements in Pharma, Biotech and Diagnostics |
|
| Table of Contents Published: 2009/01 Published by: CurrentPartnering, a division of Wildwood Ventures Limited |
| The Royalty Financing Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the royalty financing agreements entered into by the worlds leading biopharma companies.
The report provides a ... |
| Stem Cells for Cardiovascular Disease 2009 Market Report |
|
| Table of Contents Published: 2009/01 Published by: Select Biosciences, Ltd. |
| This is the latest and most up-to-date Worldwide Stem Cells Market Report from Select Biosciences, based on our continual industry coverage. Select Biosciences industry coverage in this report focuses on the technical, market, and clinical trials aspects ... |
| The World Market for Molecular Diagnostics |
|
| Table of Contents Published: 2009/01 Published by: Kalorama Information |
| The various clinical techniques and trends are discussed from the point of view of their present and potential market impact.
Market analysis in this report covers world markets for in vitro diagnostics, with focus on the developed areas of the globe ... |
| Biologic Imaging Reagents: Technologies and Global Markets |
|
| Table of Contents Published: 2009/01 Published by: BCC Research |
| The study scope includes the biologic imaging reagents that are commercial or likely to be commercialized within the next five years. Fluorescent probes and dyes, imaging nanomaterials (including quantum dots and other nanoparticles), fluorescent proteins ... |
| Cancer Bundle |
|
| Table of Contents Published: 2008/12 Published by: Trimark Publications |
| Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. If the spread is not controlled, it can result in death. Cancer is caused by both external (chemicals, radiation and viruses) and internal (hormones, immune c ... |
| Top-10 Biotech Companies - Market Outlook, 2008-2023 |
|
| Table of Contents Published: 2008/12 Published by: Visiongain |
| The biotechnology industry is a major growth area in the global healthcare market, one upon which many companies are placing their hopes. Due to developments in monoclonal antibodies, genomics and proteomics - amongst others - the biotechnology market has ... |
| European Markets for Dental Biomaterials 2009 |
|
| Table of Contents Published: 2008/12 Published by: Millennium Research Group |
| In 2008, the European dental biomaterial market approached $190 million. This value represents the total revenues from the sale of dental bone graft substitutes (BGS), tissue regeneration (TR) materials, and dental membranes. ... |
| US Markets for Orthopedic Soft Tissue Solutions 2009 |
|
| Table of Contents Published: 2008/12 Published by: Millennium Research Group |
| The US orthopedic soft tissue solutions market - comprising knee ligament reconstruction, shoulder fixation, meniscus repair, knee cartilage repair, rotator cuff reinforcement grafts, and hip arthroscopy treatments - was valued at over $1.1 billion in 200 ... |
| U.S. Cancer Molecular Diagnostics Markets |
|
| Table of Contents Published: 2008/12 Published by: Frost & Sullivan |
| This research service analyzes the market for Cancer Molecular Diagnostics within the United States. The market was divided into the Breast Cancer Molecular Diagnostics Market, Colorectal Cancer Molecular Diagnostics Market, Prostate Cancer Molecular Diag ... |
|
|
|
View Cart
Top